BriaCell Secures FDA Clearance for Prostate Cancer Therapy
PHILADELPHIA and VANCOUVER, British Columbia, Aug. 5, 2026 BriaCell Therapeutics Corp. has received U.S. Food and Drug Administration (FDA)...
prostate cancer
Advertisement
Avenda Health Expands Unfold AI Across Prostate Cancer Care
CULVER CITY, Calif., July 28, 2026 Avenda Health announced that its FDA-cleared Unfold AI platform is now being used...
Novartis’ Pluvicto Wins FDA Approval for Earlier Prostate Cancer Treatment
SILVER SPRING, Md., July 31, 2026 The U.S. Food and Drug Administration (FDA) has approved Novartis’ Pluvicto (lutetium Lu...
Pfizer Inc. Wins FDA Priority Review for Prostate Cancer Therapy
NEW YORK, July 22, 2026 Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Priority...
Telix Publishes ProstACT SELECT Study on TLX591-Tx
Melbourne, Australia & Indianapolis, Indiana, USA | July 22, 2026 Telix Pharmaceuticals announced the peer-reviewed publication of results from...
Advertisements
CoRegen Wins FDA IND Clearance for CRG-150
HOUSTON, July 7, 2026 CoRegen, Inc. has received U.S. Food and Drug Administration (FDA) Investigational New Drug (IND) clearance...
Telix Completes Phase 3 Enrollment for Illuccix in Japan
MELBOURNE, Australia, and TOKYO, Japan, July 17, 2026 Telix Pharmaceuticals has completed patient enrollment in its pivotal Phase 3...
Caris Life Sciences Expands PTEN Testing for Prostate Cancer
IRVING, Texas — July 14, 2026 Caris Life Sciences has expanded its precision oncology portfolio with the launch of...
Myriad Genetics Prolaris Study Validates Prostate Risk Test
SALT LAKE CITY, July 2, 2026 Myriad Genetics, Inc. announced the publication of the largest individual-patient-data meta-analysis evaluating its...
Francis Medical Publishes VAPOR 2 Trial Results in The Journal of Urology
MAPLE GROVE, Minn., June 30, 2026 Francis Medical announced the publication of initial results from its VAPOR 2 pivotal...
Advertisement
